Agilon Health, Inc. (NYSE:AGL) Shares Purchased by SG Americas Securities LLC

SG Americas Securities LLC raised its position in Agilon Health, Inc. (NYSE:AGL - Free Report) by 1,271.3% during the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 144,189 shares of the company's stock after purchasing an additional 133,674 shares during the period. SG Americas Securities LLC's holdings in Agilon Health were worth $624,000 at the end of the most recent reporting period.

Other hedge funds have also made changes to their positions in the company. Simplicity Wealth LLC purchased a new stake in shares of Agilon Health in the 1st quarter worth about $186,000. Pallas Capital Advisors LLC acquired a new position in Agilon Health during the first quarter worth about $66,000. Atwater Malick LLC purchased a new stake in shares of Agilon Health in the first quarter valued at about $428,000. Rhumbline Advisers lifted its holdings in shares of Agilon Health by 4.8% in the first quarter. Rhumbline Advisers now owns 439,781 shares of the company's stock valued at $1,904,000 after purchasing an additional 20,194 shares in the last quarter. Finally, Wealth Enhancement Advisory Services LLC acquired a new stake in shares of Agilon Health in the fourth quarter valued at approximately $155,000.

Agilon Health Stock Down 0.9%

Shares of AGL traded down $0.02 during mid-day trading on Wednesday, hitting $2.19. The company had a trading volume of 2,033,641 shares, compared to its average volume of 4,963,635. Agilon Health, Inc. has a 1-year low of $1.50 and a 1-year high of $7.73. The business's 50-day simple moving average is $2.90 and its 200-day simple moving average is $3.21. The stock has a market cap of $906.55 million, a PE ratio of -3.71 and a beta of 0.14.

Agilon Health (NYSE:AGL - Get Free Report) last posted its quarterly earnings results on Tuesday, May 6th. The company reported $0.03 earnings per share for the quarter, topping analysts' consensus estimates of ($0.01) by $0.04. Agilon Health had a negative net margin of 4.04% and a negative return on equity of 45.47%. The company had revenue of $1.53 billion for the quarter, compared to the consensus estimate of $1.50 billion. During the same quarter last year, the firm posted ($0.02) earnings per share. Agilon Health's revenue was down 4.5% on a year-over-year basis. On average, sell-side analysts expect that Agilon Health, Inc. will post -0.59 earnings per share for the current year.

Wall Street Analysts Forecast Growth

AGL has been the subject of several research reports. The Goldman Sachs Group lifted their price objective on Agilon Health from $2.50 to $5.00 and gave the stock a "neutral" rating in a research report on Thursday, May 8th. Sanford C. Bernstein raised Agilon Health from a "market perform" rating to an "outperform" rating and boosted their price target for the stock from $3.30 to $8.50 in a report on Tuesday, April 8th. Needham & Company LLC restated a "hold" rating on shares of Agilon Health in a research report on Friday, March 21st. TD Cowen increased their price objective on Agilon Health from $3.50 to $6.00 and gave the company a "hold" rating in a research note on Tuesday, April 15th. Finally, Cowen reiterated a "hold" rating on shares of Agilon Health in a research report on Tuesday, April 15th. Two analysts have rated the stock with a sell rating, eleven have assigned a hold rating and five have issued a buy rating to the stock. Based on data from MarketBeat.com, Agilon Health presently has a consensus rating of "Hold" and an average target price of $4.79.

Agilon Health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.